The opportunity exists for wholesale investors to express interest in an in an investment in Knewe Biosystems Limited (KBL). KBL is an unlisted, AIC registered, animal prebiotic supplementation company where the key people hold over 150 years collective experience in science, dairy and farming. The company has been granted patents in New Zealand, Australia, Europe, the UK and North America and with good prospects of future growth, is now raising the capital needed to take the business to the next stage of commercialisation.
Feeding Knewe products will reduce greenhouse emissions from the animals it is fed to, improve the welfare of animals that eat it, and importantly, provide economic benefits for farmers who feed the product to their stock. Knewe-mg is made from by-products of industrial fermentation.
- Improvement of feed utilisation by up to 20%
- Helps increase an animals overall wellbeing
- Reduces disease issues
- Lowers an animals greenhouse gas emissions, and aids in reducing nitrogen losses to groundwater
- Has measurable economic effects for farmers
- Has multinational patents
Knewe now seeks to raise, via this convertible note, further working capital of $NZ600,000 to assist funding the budgeted rapid growth in the New Zealand and UK markets. The projected financials for that rapid growth are provided in the document accessibke in the Documents section. During that budget period the group will seek to raise further capital by way of a new ordinary share issue, which is expected to be launched towards the end of 2022. Funds received from the new share issue will allow Knewe to complete its plans for successful global commercialisation of Knewe®-Mg The proposed new share offer will give investors an opportunity to purchase Knewe shares at a reasonable price prior to the projected global growth phase of the Knewe business.
Offer Amount: $NZ600,000 by way of an issue of new unsecured Convertible Notes (“CN’s”).
Issue Price: $1.00 per Note
Minimum Investment: 25,000 Notes ($NZ 25,000)
Term: 24 months from purchase. Redeemable by way of cash or ordinary shares in Knewe at the Investors discretion
Coupon: 7.0% per annum. Payable in arrears on a quarterly basis.
NB the Board of Knewe has since decided, to lift the interest rates on the twenty four month Convertible Unsecured Note from the 7.0% to the following rates:
Up to $25,000 7.85%. p.a.
$25,000 to $50,000 8.50%. p.a.
$50,000 and over 9.85%. p.a.
For further information On the KBL offer, view the flyer in the documents tab.